Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3)

British Journal of Dermatology

Volumn 137, Issue 1, 1997, Pages 109-113

  Kubo, A ^a,b   Amagai, M ^c   Hashimoto, T ^d   Doi, T ^a   Higashiyama, M ^a   Hashimoto, K ^e   Yoshikawa, K ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; COMPLEMENT COMPONENT C3; DESMOGLEIN; EDETIC ACID; FIBRINOGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOADSORPTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KERATINOCYTE; ORAL DRUG ADMINISTRATION; PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0030745698     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1997.tb03711.x     Document Type: Article

References (12)

1. Jablonska S, Chorzelski TP, Beutner EH et al. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 1975; 14: 353-9.
2. Maciejowska E, Jahlonska S, Chorzelski T. Is pemphigus herpetiformis an entity? Int J Dermatol 1987; 26: 571-7.
3. Santi CG, Maruta CW, Aoki V et al. Pemphigus herpetiformis is a rare clinical expression of nonendemic pemphigus foliaceus. fogo selvagem. and pemphigus vulgaris. J Am Acad Dermatol 1996; 34: 40-6.
4. Verdier SS, Joly P, Thomine E et al. Thiopronine-induced herpetiform pemphigus: report of a case studied by immunoelectron microscopy and immunoblot analysis. Br J Dermatol 1994; 130: 238-40.
5. Hashimoto T, Ogawa MM, Konohana A et al. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990; 94: 327-31.
6. Amagai M, Hashimoto T, Shimizu N et al. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994; 94: 59-67.
7. Amagai M, Hashimoto T, Green KJ et al. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995; 104: 895-901.
8. Amagai M. Pemphigus: autoimmunity to epidermal cell adhesion molecules. Adv Dermatol 1996; 11: 319-52.
9. Hashimoto T, Konohana A, Nishikawa T, Immunoblot assay as an aid to the diagnosis of unclassified cases of pemphigus. Arch Dermatol 1991; 127: 843-7.
10. Amagai M, Koch PJ, Nishikawa T et al. Pemphigus vulgaris antigen (Desmoglein 3) is localized in the lower epidermis. the site of blister formation in patients. J Invest Dermatol 1996; 106: 351-5.
11. Morioka S, Naito K, Ogawa H. The pathogenic role of pemphigus antibodies and proteinase in epidermal acantholysis. J Invest Dermatol 1981; 76: 337-41.
12. Hashimoto K, Shafran KM, Webber PA et al. Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. J Exp Med 1983; 157: 259-72.